Potential Medication Safety Issues with Paxlovid
ISMP has alerted pharmacists about the need to remove extra tablets from the Paxlovid blister pack (a newly authorized COVID treatment), for patients with moderate renal impairment.
Medication Safety Highlights
Who We Serve
Ambulatory Care Providers
Community/ambulatory pharmacies, clinics, surgery centers, infusion centers, homecare, and other outpatient settings.
Acute Care Providers
Integrated health network providers, including hospitals, health systems, long-term care, and rehabilitation facilities.